Related Experiment Video
Updated: Jul 9, 2026
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin
D Rosique-Robles1, J M Vicent Verge, J Borrás-Blasco
1Hospital Pharmacy, Pharmacy Service, Hospital de Sagunto, Spain.
International Journal of Clinical Pharmacology and Therapeutics
|December 15, 2007
Summary
Hypersensitivity reactions to oxaliplatin can be managed with successful desensitization, allowing continued chemotherapy for metastatic colon cancer. This approach enables patients to receive vital treatments they previously reacted to.
Area of Science:
- Oncology
- Clinical Pharmacology
Background:
- Oxaliplatin is a key chemotherapy agent for metastatic colon cancer.
- Hypersensitivity reactions (HSRs) to oxaliplatin can necessitate treatment discontinuation.
Observation:
- A patient with metastatic colon cancer experienced an anaphylactic reaction during oxaliplatin therapy.
- Alternative treatments led to cancer progression, highlighting the need to reintroduce oxaliplatin.
Findings:
- A desensitization protocol, adapted from carboplatin regimens and including dexamethasone premedication, was successfully implemented.
- The patient tolerated subsequent oxaliplatin cycles without recurrence of hypersensitivity symptoms.
Implications:
- Oxaliplatin desensitization is a viable option for patients with HSRs, even severe ones, when alternative therapies are ineffective.
- This strategy allows for the continued use of essential first-line chemotherapy, improving treatment outcomes for cancer patients.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...